NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Strain of bird flu detected on Mainland Poultry farm
Primary Sector

Strain of bird flu detected on Mainland Poultry farm

It is not the H5N1 strain circulating among wildlife around the world.

Riley Kennedy 02 Dec 2024
Should INZ be separated from MBIE?
Policy

Should INZ be separated from MBIE?

Immigration is 41% of the 'unwieldy' MBIE’s operating budget.

Jem Traylen 29 Nov 2024
NZIER and BusinessDesk play Santa
Self promotion

NZIER and BusinessDesk play Santa

Plenty of time for thrillers in retirement, PM!

Pattrick Smellie 28 Nov 2024